Journal of Drug Education
September 1, 1986
Jerome Beck, Patricia Morgan
57 citations
MDMA, also called Ecstasy or Adam, is a designer drug with both stimulant and psychedelic properties that creates a unique effect sought by recreational users. Despite its recent illegality and growing evidence of neurotoxicity, interest in MDMA is expected to persist. The article examines the drug's recreational appeal and therapeutic potential, concluding that much more research is needed to understand both its possible benefits and risks.
Journal of Drug Education
September 1, 2008
45 citations
A survey at a large public university found that recreational use of Salvia divinorum was relatively uncommon among students. The research describes patterns of use, how users obtained the substance, and their intentions to continue using it. The authors note a lack of prior research to guide public information about the drug.
Journal of Drug Education
December 1, 1996
Carrie A. Elk
22 citations
MDMA, also known as Ecstasy, is chemically related to both amphetamines and hallucinogens. Although its use among adolescents and young adults has increased over the past decade, there is insufficient systematic scientific information about MDMA and its effects. This lack of data limits or prevents MDMA from being included in drug education curricula.
Journal of Drug Education
June 1, 1985
John Paul Thompson, M. Douglas Anglin, William A. Emboden et al.
16 citations
Among 1,507 college students surveyed, 17% reported using hallucinogenic drugs. Of those, over 85% had used psilocybin mushrooms, and more than half had used mushrooms but no other hallucinogens. The data suggest a high level of experimental use of psilocybin mushrooms compared to other hallucinogens. The authors recommend that survey research distinguish mushroom use from other hallucinogens.